Evidence map›Paper›PMID 42764306›Full record

ArticleNature communications2026

RNase-mediated defence and its association with SCCmec in Staphylococcus aureus.

Kohei Kondo, Aa Haeruman Azam, Junzo Hisatsune, Shinjiro Ojima, Kotaro Chihara, Tomohiro Nakamura, Azumi Tamura, Wakana Yamashita, Satoshi Nakano, Shoko Kutsuno and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Kohei KondoAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID http://orcid.org/0009-0006-6451-2728
Aa Haeruman AzamDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Junzo HisatsuneAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9330-4203
Shinjiro OjimaDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Kotaro ChiharaDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID http://orcid.org/0000-0002-2694-2560
Tomohiro NakamuraDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Azumi TamuraDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Wakana YamashitaDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Satoshi NakanoAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID http://orcid.org/0000-0002-8987-0250
Shoko KutsunoAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Yo SugawaraAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID http://orcid.org/0000-0002-9897-3905
Jumpei UchiyamaDepartment of Bacteriology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.ORCID http://orcid.org/0000-0003-0846-0100
Masayuki AmagaiDepartment of Dermatology, Keio University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0003-3314-7052
Tetsuo YamaguchiDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.
Yoshikazu IshiiDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.
Koichi WatashiDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID http://orcid.org/0000-0002-4536-9966
Yoshimasa TakahashiResearch Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6342-4087
Kotaro KigaDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID http://orcid.org/0000-0002-0248-6951
Motoyuki SugaiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan. sugai.m@jihs.go.jp.ORCID http://orcid.org/0000-0001-9252-7739

Funding

Japan Agency for Medical Research and Development (AMED) JP25fk0108699
6 · The paper itself

Abstract

The rise of antibiotic resistance in Staphylococcus aureus is a major threat to global health. Resistance often emerges when bacteria acquire foreign DNA elements, such as the SCCmec cassette that makes strains resistant to nearly all β-lactam antibiotics. Yet, not all S. aureus lineages take up these elements equally, raising the question of what prevents some strains from becoming drug-resistant. Here we identify a previously unknown defence factor that explains this mystery in a common skin lineage (ST188), frequently isolated from patients with atopic dermatitis. Such defence factor is encoded by a gene, which we name sadR, that is present in methicillin-susceptible ST188 strains but absent from resistant counterparts. SadR exhibits RNase activity that provides anti-bacteriophage and anti-plasmid defence, thus acting as a barrier to the uptake of mobile genetic elements. Gene sadR is found in methicillin-susceptible strains in S. aureus lineages other than ST188, and is consistently located adjacent to rlmH, the canonical SCCmec integration site. Moreover, SadR homologues are widespread across staphylococci and other bacteria suggesting a previously unrecognised family of RNase-based defence systems.

Indexed as

Bacterial ProteinsRibonucleasesStaphylococcus aureusHumansPlasmidsBacterial ProteinsRibonucleases

Identifiers

PMID42764306
PMCPMC13590631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.